Case Control Study
Copyright ©The Author(s) 2023.
World J Hepatol. Jul 27, 2023; 15(7): 904-913
Published online Jul 27, 2023. doi: 10.4254/wjh.v15.i7.904
Table 1 Patient characteristics for the third trimester and after delivery
ParametersNormal range1ICP
Control
3. trimester, n = 98
Postpartal, n = 17
3. trimester, n = 228
Postpartal, n = 38
Age (years)31.0 ± 4.2a28.3 ± 3.5c32.2 ± 5.232.9 ± 4.3
Bile acids (µmol/L)2-539.0 ± 29.4d23.7 ± 11.6a6.8 ± 6.92.3 ± 1.2
AST (U/L)< 35116 ± 106d88.2 ± 80a26 ± 2728 ± 6
ALT (U/L)< 35211 ± 202d127 ± 106b18 ± 2615 ± 8
GGT (U/L)< 4023 ± 2248 ± 40a30 ± 5518 ± 18
AP (U/L)35-105178 ± 68182 ± 73150 ± 95283 ± 344
Bilirubin total (mg/dL)< 1.30.65 ± 0.27d0.52 ± 0.560.47 ± 0.260.65 ± 0.35
M30 (U/L)< 200432 ± 220a293 ± 75a339 ± 207296 ± 50
M65 (U/L)< 4001180 ± 571d777 ± 426d680 ± 343486 ± 89
Creatinine (mg/dL)< 1.30.69 ± 0.38a0.88 ± 0.39a0.57 ± 0.120.61 ± 0.12
Urea (mg/dL)< 5019.8 ± 6.8a25.5 ± 6.4b16.9 ± 4.519.4 ± 5.3
Uric acid (mg/dL)3.5-7.2 5.6 ± 2.4d6.3 ± 2.83.9 ± 0.94.7 ± 1.0
Total protein (g/L)66-8367.6 ± 4.2b65.2 ± 6.864.7 ± 4.466.3 ± 9.5
Albumin (g/L)38-5935.6 ± 2.736.3 ± 12.735.7 ± 2.7
Leukocytes (1/nL)3.7-10.08.8 ± 2.4d12.0 ± 3.4a10.8 ± 3.015.5 ± 4.8
Erythrocytes (1/pL)4.1-5.13.9 ± 0.43.6 ± 0.64.0 ± 0.43.7 ± 0.5
Hemoglobin (g/dL)12-1611.4 ± 1.110.3 ± 1.511.7 ± 1.310.8 ± 1.5
Hematocrit (%)36-4333 ± 330 ± 6
MCV (/pL)80-9686.1 ± 4.488.0 ± 3.5
Platelets (1/nL)150-360228 ± 72241 ± 61227 ± 68237 ± 61
Haptoglobin (g/L)0.3-2.00.8 ± 0.41.0 ± 0.8
Quick (%)70-120123.3 ± 5.1119.4 ± 21.1123.0 ± 13.0124.5 ± 4.4
INR< 1.10.91 ± 0.040.90 ± 0.030.90 ± 0.030.90 ± 0.03
Grade of steatosis in United States (0-3)00.42 ± 0.50a0.14 ± 0.380.18 ± 0.420.00 ± 0.00
Spleen size (cm)< 1111.4 ± 1.911.3 ± 1.111.1 ± 1.511.1 ± 1.7
Liver stiffness (kPa)< 67.3 ± 3.0c5.8 ± 1.7d6.2 ± 2.34.2 ± 0.9
CAP (dB/m)< 290 (S3)206 ± 49c213 ± 43228 ± 39224 ± 46